[HTML][HTML] The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression�…
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
The global gap in treatment coverage for major depressive disorder in 84 countries from 2000-2019: A systematic review and Bayesian meta-regression analysis.
M Moitra, D Santomauro, PY Collins, T Vos…�- Plos�…, 2022 - europepmc.org
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression analysis
M Moitra, D Santomauro, PY Collins, T Vos…�- PLoS�…, 2022 - pure.johnshopkins.edu
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression analysis
H Whiteford�- PLoS Medicine, 2022 - search.proquest.com
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
The global gap in treatment coverage for major depressive disorder in 84 countries from 2000-2019: A systematic review and Bayesian meta-regression analysis.
M Moitra, D Santomauro, PY Collins, T Vos…�- PLoS Medicine, 2022 - go.gale.com
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
[HTML][HTML] The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression�…
M Moitra, D Santomauro, PY Collins, T Vos…�- PLoS�…, 2022 - ncbi.nlm.nih.gov
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
The global gap in treatment coverage for major depressive disorder in 84 countries from 2000-2019: A systematic review and Bayesian meta-regression analysis
M Moitra, D Santomauro, PY Collins, T Vos…�- PLoS�…, 2022 - pubmed.ncbi.nlm.nih.gov
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
[CITATION][C] The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: a systematic review and Bayesian meta-regression�…
M Moitra, D Santomauro, PY Collins, T Vos…�- PLoS�…, 2022 - espace.library.uq.edu.au
The treatment coverage for major depressive disorder (MDD) is low in many parts of the
world despite MDD being a major contributor to disability globally. Most existing reviews of�…
world despite MDD being a major contributor to disability globally. Most existing reviews of�…
The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression analysis
M Moitra, D Santomauro, PY Collins, T Vos…�- PLOS�…, 2022 - open.journal4submit.com
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
The global gap in treatment coverage for major depressive disorder in 84 countries from 2000-2019: A systematic review and Bayesian meta-regression analysis.
M Moitra, D Santomauro, PY Collins, T Vos…�- Plos�…, 2022 - europepmc.org
Background The treatment coverage for major depressive disorder (MDD) is low in many
parts of the world despite MDD being a major contributor to disability globally. Most existing�…
parts of the world despite MDD being a major contributor to disability globally. Most existing�…